Latest Trials
| EudraCT Number: 2016-003361-25 | Sponsor Protocol Number: SHP640-303 | Start Date: | |||||||||||
| Sponsor Name: Shire Human Genetic Therapies, Inc. | |||||||||||||
| Full Title: A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in... | |||||||||||||
| Medical condition: Bacterial Conjunctivitis | |||||||||||||
|
|||||||||||||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) EE (Completed) HU (Completed) ES (Completed) PL (Completed) AT (Completed) FR (Completed) GB (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||